Showing 1 - 10 of 21
We evaluate the welfare effects of differential pricing, voluntary licensing, and compulsory licensing in the Indian market for oral anti-diabetic (OAD) drugs. This market includes a new class of molecules called DPP-4 inhibitors, all of which are under patent protection in India. The Indian...
Persistent link: https://www.econbiz.de/10013035611
drugs in the wholesale markets. We also find that higher concentration of private retailers amplifies the impact, indicating …
Persistent link: https://www.econbiz.de/10014081925
Persistent link: https://www.econbiz.de/10011714400
Persistent link: https://www.econbiz.de/10012060267
Persistent link: https://www.econbiz.de/10012042464
Do upstream research shocks directly and contemporaneously impact related but disconnected downstream product markets? We explore this question using a natural experiment involving the New Delhi Metallo-Beta-Lactamase 1 superbug pathogenic outbreak in India. Using a difference-in-differences...
Persistent link: https://www.econbiz.de/10012533389
This paper examines the relationship between exogenous demand shock and market structure in India’s influenza vaccine markets. Using a novel dataset of detailed purchasing information for vaccines in India, and exploiting the 2009-10 global H1N1 pandemic as an exogenous demand shock, we...
Persistent link: https://www.econbiz.de/10014033643
This paper examines the relationship between exogenous demand shocks and market structure in India’s influenza vaccine markets. Using a novel dataset of detailed purchasing information for vaccines in the country, and exploiting the occurrence of the 2009-10 global H1N1 pandemic as an...
Persistent link: https://www.econbiz.de/10014035294
Persistent link: https://www.econbiz.de/10009552059
Persistent link: https://www.econbiz.de/10010366952